BioTech Firm Says Heller Ehrman Patent Gaffe Cost It $100M

Law360, New York (October 29, 2012, 2:28 PM EDT) -- A biotechnology firm that allegedly lost $100 million after Heller Ehrman LLP failed to notify it of a lapsed patent application asked a California bankruptcy judge on Friday to allow its late malpractice claims in the law firm's Chapter 11 case, arguing it only discovered the abandoned application after the 2009 claims deadline.

Iris BioTechnologies Inc. says Heller Ehrman never informed company executives that the U.S. Patent and Trademark Office had requested more paperwork before it would allow the company to broaden its application for a...
To view the full article, register now.